The University of Queensland has struck a deal with Canadian health and wellness company PreveCeutical Medical which could revolutionise the way patients take medical cannabis.
19 November 2021
A University of Queensland start-up company, developing a potential new treatment for obesity-related liver disease, has secured a seed investment of $1.3 million from IP Group, a UK-based intellectual property business.
20 October 2021
A pilot facility at The University of Queensland could be producing mRNA vaccines and cancer therapies for research and development within months after receiving backing from the Australian Government.
29 April 2021
Synthetic cannabidiol, better known as CBD, has been shown for the first time to kill the bacteria responsible for gonorrhoea, meningitis and legionnaires disease.
20 January 2021
